Physician
Bay Area Retina Associates
Bay Area Retina Associates was paid $30.39M by Medicaid between Jan 2018 and Dec 2024, across 21 billing codes. Its largest line is J0178, Injection, aflibercept, 1 mg — 64% of everything it billed.
33Billing provider infoBAY AREA RETINA ASSOCIATES
WALNUT CREEK, CA 94598
WALNUT CREEK, CA 94598
33aNPI1174557805assigned 07/10/2006
33bProvider typeRetina Specialist (Ophthalmology) Physician
28Total paid$30.39M
24GClaims158,413
24DCodes billed21
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Retina Specialist (Ophthalmology) Physician providers in California
Rank by total paid#1 of 45
Median peer was paid$55K
This provider vs. median551×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 15,373 | $1.50M | |
| 2019 | 18,890 | $1.93M | |
| 2020 | 17,848 | $2.89M | |
| 2021 | 23,266 | $4.15M | |
| 2022 | 24,337 | $5.39M | |
| 2023 | 29,514 | $6.93M | |
| 2024incomplete | 29,185 | $7.60M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 64% | 16,371 | 15,556 | $19.60M |
| 67028 | Intravitreal injection of a pharmacologic agent | 19% | 34,741 | 28,648 | $5.83M |
| J2777 | Injection, faricimab-svoa, 0.1 mg | 5.0% | 1,108 | 1,036 | $1.53M |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 2.5% | 23,302 | 21,617 | $752K |
| 92134 | 2.1% | 33,637 | 31,713 | $648K | |
| 92250 | 2.1% | 21,980 | 21,171 | $643K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 1.5% | 11,863 | 11,545 | $464K |
| J9035 | Injection, bevacizumab, 10 mg | 1.1% | 4,068 | 3,622 | $345K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 3,150 | 3,116 | $122K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | <1% | 2,361 | 2,306 | $116K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 1,799 | 1,784 | $115K |
| 92235 | <1% | 1,644 | 1,599 | $110K |
9 more codes
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 1,924 | $99K |
| Q5124 | Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg | <1% | 12 | $6K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 42 | $4K |
| 92225 | <1% | 78 | $3K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 94 | $3K |
| 92226 | <1% | 115 | $2K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 25 | $1K |
| 76512 | <1% | 29 | $1K | |
| J7999 | Compounded drug, not otherwise classified | <1% | 70 | $1K |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRANCHOD, TUSHAR (PARTNER)